Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(dimethylamino)-1-((2-(3-methoxyphenyl)phenoxy)methyl)ethyl Hydrogensuccinate Hydrochloride
2. Mci 9042
3. Mci-9042
4. Mono-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl)succinate Hydrochloride
5. Sarpogrelate
1. 135159-51-2
2. Sarpogrelate Hcl
3. Anplag
4. Mci-9042
5. Mci 9042
6. Sarpogrelate (hydrochloride)
7. Sarpogrelate Hydrochloride [jan]
8. Sarpogrelatehydrochloride
9. Fqn8n8qp1b
10. C24h32clno6
11. Dsstox_rid_81804
12. Dsstox_gsid_46662
13. Chembl541829
14. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid;hydrochloride
15. Butanedioic Acid, Esters, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester, Hydrochloride, (+-)-
16. Cas-135159-51-2
17. Dsstox_cid_26662
18. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic Acid Hydrochloride
19. Butanedioic Acid 1-[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl] Ester Hydrochloride
20. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester, Hydrochloride, (+-)-
21. Ncgc00167489-01
22. Ncgc00167489-03
23. Unii-fqn8n8qp1b
24. Anplag (tn)
25. Mfcd00887582
26. Schembl120568
27. Dtxsid8046662
28. Chebi:32122
29. Amy8866
30. Sarpogrelate Hydrochloride- Bio-x
31. Sarpogrelate Hydrochloride (jp17)
32. Bcp07360
33. Tox21_112490
34. S3706
35. Akos015889582
36. Tox21_112490_1
37. Ac-1598
38. Ccg-269415
39. H59s512
40. Ks-5244
41. (+/-)-sarpogrelate Hydrochloride
42. Bs164394
43. Hy-10564
44. Sarpogrelate Hydrochloride [who-dd]
45. Ls-187118
46. Sarpogrelate Hydrochloride, >=98% (hplc)
47. Ft-0602637
48. Sarpogrelate Hydrochloride, (+/-)-
49. D01624
50. A806893
51. J-006654
52. Q27278133
53. 4-((1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yl)oxy)-4-oxobutanoic Acid Hcl
54. 4-(1-(dimethylamino)-3-(2-(3-methoxyphenethyl)phenoxy)propan-2-yloxy)-4-oxobutanoic Acid Hydrochloride
55. 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxidanylidene-butanoic Acid Hydrochloride
56. 4-{[1-(dimethylamino)-3-{2-[2-(3-methoxyphenyl)ethyl]phenoxy}propan-2-yl]oxy}-4-oxobutanoic Acid Hydrochloride
57. Butanedioic Acid, 1-(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester, Hydrochloride (1:1)
58. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester, Hydrochloride
59. Butanedioic Acid, Mono(2-(dimethylamino)-1-((2-(2-(3-methoxyphenyl)ethyl)phenoxy)methyl)ethyl) Ester, Hydrochloride, (+/-)-
60. Succinic Acid Mono-(1-dimethylaminomethyl-2-(2-[2-(3-methoxyphenyl)ethyl]phenoxy)ethyl) Ester Hydrochloride
Molecular Weight | 466.0 g/mol |
---|---|
Molecular Formula | C24H32ClNO6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 14 |
Exact Mass | 465.1918154 g/mol |
Monoisotopic Mass | 465.1918154 g/mol |
Topological Polar Surface Area | 85.3 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 540 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Fibrinolytic Agents
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)
Registration Number : 225MF10228
Registrant's Address : Plot No. :B-7/31, 32, 33. Krishna Industrial Estate, Opp. BIDC, Gorwa, Baroda-390 016, Gujarat, India
Initial Date of Registration : 2013-12-18
Latest Date of Registration : --
Registration Number : 301MF10004
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2019-05-15
Latest Date of Registration : --
Registration Number : 227MF10170
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2015-06-18
Latest Date of Registration : --
Registration Number : 221MF10040
Registrant's Address : 121-15 Torino, Koka-cho, Koka City, Shiga Prefecture
Initial Date of Registration : 2009-02-23
Latest Date of Registration : --
Registration Number : 231MF10008
Registrant's Address : #204, Sandan-gil, Jeonui-myeon, Sejong, Korea
Initial Date of Registration : 2019-01-10
Latest Date of Registration : --
Registrant Name : Korea Biochem Pharmaceutical Co., Ltd.
Registration Date : 2019-06-25
Registration Number : 20190625-209-J-375
Manufacturer Name : Korea Biochem Pharmaceutical Co., Ltd.
Manufacturer Address : 204 Sandan-gil, Jeonui-myeon, Sejong Special Self-Governing City
Registration Number : 220MF10185
Registrant's Address : 1062-8 Honjo, Nishikata-cho, Tochigi City, Tochigi Prefecture
Initial Date of Registration : 2008-07-31
Latest Date of Registration : --
Registration Number : 228MF10193
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2016-10-05
Latest Date of Registration : --
Registration Number : 230MF10062
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2018-05-08
Latest Date of Registration : --
Registration Number : 228MF10104
Registrant's Address : 343, Sapyeong-daero, Seocho-gu, Seoul, Korea
Initial Date of Registration : 2016-06-06
Latest Date of Registration : --
Registrant Name : Jeil Pharmaceutical Co., Ltd.
Registration Date : 2020-07-10
Registration Number : 20200710-209-J-688
Manufacturer Name : Jeil Pharmaceutical Co., Ltd.
Manufacturer Address : 7, Cheonggang-ga-chang-ro, Baekam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do (B-dong and others)
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?